1 Liu Y, "orrelation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis" 29 : 16-, 2010
2 Bianchini G, "Triplenegative breast cancer: challenges and opportunities of a heterogeneous disease" 13 : 674-690, 2016
3 Boyle P, "Triple-negative breast cancer: epidemiological considerations and recommendations" 23 (23): vi7-vi12, 2012
4 Salvucci O, "The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study" 97 : 275-283, 2006
5 Hassan S, "The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer" 175 : 66-73, 2009
6 Orimo A, "Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion" 121 : 335-348, 2005
7 Kang H, "Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer" 7 : R402-R410, 2005
8 Haribabu B, "Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization" 272 : 28726-28731, 1997
9 Yan M, "Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers" 13 : R47-, 2011
10 Wolff AC, "Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update" 31 : 3997-4013, 2013
1 Liu Y, "orrelation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis" 29 : 16-, 2010
2 Bianchini G, "Triplenegative breast cancer: challenges and opportunities of a heterogeneous disease" 13 : 674-690, 2016
3 Boyle P, "Triple-negative breast cancer: epidemiological considerations and recommendations" 23 (23): vi7-vi12, 2012
4 Salvucci O, "The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study" 97 : 275-283, 2006
5 Hassan S, "The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer" 175 : 66-73, 2009
6 Orimo A, "Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion" 121 : 335-348, 2005
7 Kang H, "Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer" 7 : R402-R410, 2005
8 Haribabu B, "Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization" 272 : 28726-28731, 1997
9 Yan M, "Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers" 13 : R47-, 2011
10 Wolff AC, "Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update" 31 : 3997-4013, 2013
11 Hudis CA, "Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system" 25 : 2127-2132, 2007
12 Elston CW, "Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up" 19 : 403-410, 1991
13 Muller A, "Involvement of chemokine receptors in breast cancer metastasis" 410 : 50-56, 2001
14 Yu S, "High level of CXCR4 in triplenegative breast cancer specimens associated with a poor clinical outcome" 67 : 369-375, 2013
15 Chu QD, "High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome" 159 : 689-695, 2010
16 Zou YR, "Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development" 393 : 595-599, 1998
17 Kobayashi T, "Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis" 123 : 733-745, 2010
18 Zhang Z, "Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis" 14 : 49-, 2014
19 Nagasawa T, "Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1" 382 : 635-638, 1996
20 Chen HW, "Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer" 13 : 410-416, 2013
21 Baggiolini M, "Chemokines and leukocyte traffic" 392 : 565-568, 1998
22 Balkwill F, "Cancer and the chemokine network" 4 : 540-550, 2004
23 Smith MC, "CXCR4 regulates growth of both primary and metastatic breast cancer" 64 : 8604-8612, 2004
24 Lefort S, "CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients" 36 : 1211-1222, 2017
25 Mirisola V, "CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of diseasefree and overall survival" 45 : 2579-2587, 2009
26 Guo F, "CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks" 35 : 816-826, 2016
27 Alda Losi Guembarovski, "CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer" Springer Nature 45 (45): 741-750, 2018
28 Hammond ME, "American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer" 28 : 2784-2795, 2010
29 Lebert JM, "Advances in the systemic treatment of triple-negative breast cancer" 25 (25): S142-S150, 2018
30 Domanska UM, "A review on CXCR4/CXCL12 axis in oncology: no place to hide" 49 : 219-230, 2013
31 Samarendra H, "A meta-analysis of CXCL12 expression for cancer prognosis" 117 : 124-135, 2017
32 Huang EH, "A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer" 155 : 231-236, 2009